31 – 40 of 102
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Effects of alkaline sphingomyelinase on cholesterol absorption in intestinal Caco-2 cells
2009) 50th International Conference on Bioscience of Lipids In Chemistry and Physics of Lipids 160. p.20-21(
- Contribution to journal › Published meeting abstract
-
Mark
Ezetimibe Inhibits Expression of Acid Sphingomyelinase in Liver and Intestine.
(
- Contribution to journal › Article
- 2008
-
Mark
Anti proliferative activity on human colon cancer cells treated in vitro with extracts from Bolivian foods and other plants
2008) 20th Meeting of the European Association for Cancer Research In EJC Supplements 6(9). p.198-198(
- Contribution to journal › Published meeting abstract
-
Mark
Alkaline Sphingomyelinase (Npp7) And Its Implications In Intestinal Tumorigenesis And Inflammation
(
- Contribution to journal › Published meeting abstract
-
Mark
Ursolic acid inhibits the formation of aberrant crypt foci and affects colonic sphingomyelin hydrolyzing enzymes in azoxymethane-treated rats
(
- Contribution to journal › Article
-
Mark
Dietary Sphingomyelin Inhibits Colonic Tumorigenesis with an Up-regulation of Alkaline Sphingomyelinase Expression in ICR Mice
(
- Contribution to journal › Article
- 2007
-
Mark
Purification and characterization of human intestinal neutral ceramidase.
(
- Contribution to journal › Article
-
Mark
Sphingomyelinase and ceramidase in the intestinal tract
(
- Contribution to journal › Article
-
Mark
Human meconium contains significant amounts of alkaline sphingomyelinase, neutral ceramidase, and sphingolipid metabolites.
(
- Contribution to journal › Article
-
Mark
Identification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesis.
(
- Contribution to journal › Article